Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study
Authors' conclusion
CGM using Dexcom G6 systems is a credible alternative to SMBG for monitoring glucose levels when insulin-treated pilots fly commercial aircraft.
Study context
- Population
- Aircraft pilots with insulin-treated diabetes in the UK, Ireland and Austria, certified to fly commercial aircraft within the European Aviation Safety Agency ARA.MED.330 protocol; 7 T1D, 1 type 3c diabetes; median age 48.5 years; median diabetes duration 11.5 years
- Participants
- 8 male pilots
- Comparison
- Continuous glucose monitoring (CGM) vs self-monitored blood glucose (SMBG)
- Outcome
- Agreement of contemporaneous SMBG and CGM values (pre- and in-flight)
Methodological detailspreliminary
- Preliminary
Main finding
As reported in the abstract
Correlation coefficient (R)
0.843
P < 0.001
874 paired values
Mean absolute relative difference
9.39 %
SD 3.12
Original publication
Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study. Diabetes Technol Ther. Published 31 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →